# Combination Methotrexate and Infliximab

> **NCT00432432** · PHASE4 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 38 (actual)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

- **DRUG:** Infliximab and MTX

## Key facts

- **NCT ID:** NCT00432432
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2006-08
- **Final completion:** 2006-10
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2012-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00432432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00432432, "Combination Methotrexate and Infliximab". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00432432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*